Navigation Links
ABSOLOK EXTRA Single Clip Appliers

ProductsABSOLOK EXTRA Single Clip Appliers
Company Ethicon, Inc.
Item ABSOLOK EXTRA Single Clip Appliers
Features 
  • Clip Appliers apply a polydioxanone (PDS) radiotransparent clip that is absorbed via hydrolysis completely within seven months.
  • 360° interlocking clip closes audibly and produces tactile feedback, completely encircles vessel with positive closure.
  • Absorbable PDS clip absorbs by hydrolysis in approximately seven months.
  • Description The ABSOLOK EXTRA Ligating Clip Applier is a reusable instrument that delivers absorbable ligating clips. The instrument and clips are designed to offer a fast, efficient means of ligation of tubular structures where an absorbable ligating device is indicated. The instrument optimizes visibility of the clip at the ligation site and facilitates access to virtually all vessels and/or tissues. The ligating clips are positioned around a tubular structure and closed by applying pressure to the handles of the applier.

    The ABSOLOK EXTRA Ligating Clips are sterile, single patient use clips produced from polydioxanone polymer and are designed for use as absorbable ligatures. The clips are radiotransparent and therefore will not interfere with interpretation of postoperative X-ray, CT, or MR scans.

    The ABSOLOK EXTRA Ligating Clips and Clip Appliers have application for use on tubular structures or vessels wherever ligating clips are indicated. The tissue being ligated should be consistent with the size of the clip.
    Info Ethicon, Inc.
    Customer Service: (800) 4-ETHICON
    Web site: http://www.ethicon.com/

    Related medicine products :

    1. EXTRA LARGE CHECK-FLO INTRODUCERS
    2. EXTRAHAND™ Balloon Retractor
    3. LIGACLIP EXTRA Single Clip Ligating Appliers
    4. Single Skin Hook
    5. Single Tantalum Clip (50 Style)
    6. Single Beam
    7. Single Plate Molteno Implant (S1)
    8. Pressure Ridge Single Plate Molteno Implant (D1)
    9. Cottle Single Hook
    10. Goldman Single Hook
    11. Joseph Single Hook
    (Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
    (Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving multi-billion ... head shops –can’t help but be heartened by the industry’s current surge. But another ... described as “skunk smell.” At last they can simply, safely and effectively end ...
    (Date:4/25/2017)... ... ... There is no better place in South Florida to undergo two common heart ... of Consumer Reports focused on heart health. , The magazine gave Memorial ... bypass and aortic valve replacement procedures. , Consumer Reports rated Memorial’s Cardiac ...
    (Date:4/24/2017)... , ... April 24, 2017 , ... ... yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American ... pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in a ...
    (Date:4/24/2017)... ... 2017 , ... As part of the nationwide Days of Remembrance effort led ... Holocaust and Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced ... trip to Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip ...
    Breaking Medicine News(10 mins):
    (Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
    (Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
    (Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
    Breaking Medicine Technology: